<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33608813</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Implication of post-translationally modified SOD1 in pathological aging.</ArticleTitle><Pagination><StartPage>507</StartPage><EndPage>515</EndPage><MedlinePgn>507-515</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-021-00332-2</ELocationID><Abstract><AbstractText>Why certain people relish healthy aging throughout their life span while others suffer pathological consequences? In this review, we focus on some of the dominant paradigms of pathological aging, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD), and predict that the antioxidant superoxide dismutase 1 (SOD1), when post-translationally modified by aging-associated oxidative stress, acts as a mechanism to accelerated aging in these age-related neurodegenerative diseases. Oxidative modifications of natively reduced SOD1 induce pathological confirmations such as misfolding, leading to a subsequent formation of monomeric, oligomeric, and multimeric aggregates. Misfolded SOD1 propagates like prions from cell to cell. These modified conformations are detected in brain tissues in ALS, AD, and PD, and are considered a contributing factor to their initial pathogenesis. We have also elaborated on oxidative stress-induced non-native modifications of SOD1 and offered a logistic argument on their global implication in accelerated or pathological aging in the context of ALS, AD, and PD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shafiq</LastName><ForeName>Kashfia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 27, King's College Cir, Toronto, ON, M5S, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanghai</LastName><ForeName>Nitesh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, R3E 0T5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pathological Department, Hebei North University, Zhangjiakou, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jiming</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2859-9831</Identifier><AffiliationInfo><Affiliation>Department of Human Anatomy and Cell Science, Rady Faculty of Health Science, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada. Jiming.Kong@umanitoba.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease (AD)</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease (PD)</Keyword><Keyword MajorTopicYN="N">Pathological aging</Keyword><Keyword MajorTopicYN="N">Post-translational modification</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33608813</ArticleId><ArticleId IdType="pmc">PMC8110659</ArticleId><ArticleId IdType="doi">10.1007/s11357-021-00332-2</ArticleId><ArticleId IdType="pii">10.1007/s11357-021-00332-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist. 2015;55(6):901&#x2013;911. doi: 10.1093/geront/gnv130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnv130</ArticleId><ArticleId IdType="pmc">PMC4861644</ArticleId><ArticleId IdType="pubmed">26561272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States. United States Census Bureau, Economics and Statistics Administration, US; 2014.</Citation></Reference><Reference><Citation>Poirier TI, Butler LM, Devraj R, Gupchup GV, Santanello C, Lynch JC. A cultural competency course for pharmacy students. Am J Pharm Educ. 2009;73(5)81. 10.5688/aj730581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739064</ArticleId><ArticleId IdType="pubmed">19777096</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajah M, Bastianetto S, Bromley-Brits K, Cools R, D&#x2019;Esposito M, Grady C, et al. Biological changes associated with healthy versus pathological aging: a symposium review. Ageing Res Rev. 2009;8(2):140&#x2013;146. doi: 10.1016/j.arr.2009.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2009.01.003</ArticleId><ArticleId IdType="pmc">PMC2671241</ArticleId><ArticleId IdType="pubmed">19274854</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonker MJ, Melis JP, Kuiper RV, van der Hoeven TV, Wackers PF, Robinson J, et al. Life spanning murine gene expression profiles in relation to chronological and pathological aging in multiple organs. Aging Cell. 2013;12(5):901&#x2013;909. doi: 10.1111/acel.12118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12118</ArticleId><ArticleId IdType="pmc">PMC3772962</ArticleId><ArticleId IdType="pubmed">23795901</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetrius LA, Magistretti PJ, Pellerin L. Alzheimer&#x2019;s disease: the amyloid hypothesis and the Inverse Warburg effect. Front Physiol. 2015;5:522. doi: 10.3389/fphys.2014.00522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00522</ArticleId><ArticleId IdType="pmc">PMC4294122</ArticleId><ArticleId IdType="pubmed">25642192</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging. 1992;13(1):179&#x2013;189. doi: 10.1016/0197-4580(92)90027-U.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-4580(92)90027-U</ArticleId><ArticleId IdType="pubmed">1311804</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22(17):R741&#x2013;RR52. doi: 10.1016/j.cub.2012.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2012.07.024</ArticleId><ArticleId IdType="pubmed">22975005</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas DB, Rozas P, Traub FM, Woehlbier U, Brown RH, Bosco DA, et al. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2018;115(32):8209&#x2013;8214. doi: 10.1073/pnas.1801109115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander GM, Erwin KL, Byers N, Deitch JS, Augelli BJ, Blankenhorn EP, Heiman-Patterson TD. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res Mol Brain Res. 2004;130(1-2):7&#x2013;15. doi: 10.1016/j.molbrainres.2004.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molbrainres.2004.07.002</ArticleId><ArticleId IdType="pubmed">15519671</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio F, Maduro C, Fisher EM, Acevedo-Arozena A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis Model Mech. 2019;12(1):dmm037424. 10.1242/dmm.037424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RK, Fisher EM, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain. 2013;136(8):2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST, Brown RH., Jr Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13(11):1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J, Zhang Z. Structural properties and interaction partners of familial ALS-associated SOD1 mutants. Front Neurol. 2019;10:527. doi: 10.3389/fneur.2019.00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00527</ArticleId><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill C, Phelan JP, Hatzipetros T, Kidd JD, Tassinari VR, Levine B, et al. SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS. Sci Rep. 2019;9(1):1&#x2013;13. doi: 10.1038/s41598-019-43164-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-43164-z</ArticleId><ArticleId IdType="pmc">PMC6491559</ArticleId><ArticleId IdType="pubmed">31040321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S, Zhao A, Adams KL, Jayson CK, Sawaya MR, Guenther EL, Pan AC, Ngo J, Moore DM, Soriaga AB, Do TD, Goldschmidt L, Nelson R, Bowers MT, Koehler CM, Shaw DE, Novitch BG, Eisenberg DS. Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (ALS) Proc Natl Acad Sci U S A. 2017;114(33):8770&#x2013;8775. doi: 10.1073/pnas.1705091114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705091114</ArticleId><ArticleId IdType="pmc">PMC5565441</ArticleId><ArticleId IdType="pubmed">28760994</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Villanueva JF, D&#xed;az-Molina R, Garc&#xed;a-Gonz&#xe1;lez V. Protein folding and mechanisms of proteostasis. Int J Mol Sci. 2015;16(8):17193&#x2013;17230. doi: 10.3390/ijms160817193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160817193</ArticleId><ArticleId IdType="pmc">PMC4581189</ArticleId><ArticleId IdType="pubmed">26225966</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliore L, Copped&#xe8; F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res. 2009;674(1-2):73&#x2013;84. doi: 10.1016/j.mrgentox.2008.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrgentox.2008.09.013</ArticleId><ArticleId IdType="pubmed">18952194</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z-J, Feng Y-H, Gu B-H, Li Y-M, Chen H. The post-translational modification, SUMOylation, and cancer. Int J Oncol. 2018;52(4):1081&#x2013;1094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5843405</ArticleId><ArticleId IdType="pubmed">29484374</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Li X, Li J-D. The roles of post-translational modifications on &#x3b1;-Synuclein in the pathogenesis of Parkinson&#x2019;s diseases. Front Neurosci. 2019;13:381. doi: 10.3389/fnins.2019.00381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00381</ArticleId><ArticleId IdType="pmc">PMC6482271</ArticleId><ArticleId IdType="pubmed">31057362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MT, Beal MF. The oxidative damage theory of aging. Clin Neurosci Res. 2003;2(5-6):305&#x2013;315. doi: 10.1016/S1566-2772(03)00007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1566-2772(03)00007-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinelli P, Navarro S, Gra&#xf1;a-Montes R, Ba&#xf1;&#xf3;-Polo M, Fern&#xe1;ndez MR, Papaleo E, Ventura S. A single cysteine post-translational oxidation suffices to compromise globular proteins kinetic stability and promote amyloid formation. Redox Biol. 2018;14:566&#x2013;575. doi: 10.1016/j.redox.2017.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2017.10.022</ArticleId><ArticleId IdType="pmc">PMC5684091</ArticleId><ArticleId IdType="pubmed">29132128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Shang H, Qiu X, Fujiwara N, Cui L, Li X-M, Gao TM, Kong J. Oxidative modification of cysteine 111 promotes disulfide bond-independent aggregation of SOD1. Neurochem Res. 2012;37(4):835&#x2013;845. doi: 10.1007/s11064-011-0679-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-011-0679-8</ArticleId><ArticleId IdType="pubmed">22219129</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Pecheur M, Bourdon E, Paly E, Farout L, Friguet B, London J. Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice. FEBS Lett. 2005;579(17):3613&#x2013;3618. doi: 10.1016/j.febslet.2005.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2005.05.048</ArticleId><ArticleId IdType="pubmed">15961078</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, Cashman NR, Kondejewski LH, Chakrabartty A. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem. 2002;277(49):47551&#x2013;47556. doi: 10.1074/jbc.M207356200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207356200</ArticleId><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins D, English AM. SOD1 oxidation and formation of soluble aggregates in yeast: relevance to sporadic ALS development. Redox Biol. 2014;2:632&#x2013;639. doi: 10.1016/j.redox.2014.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2014.03.005</ArticleId><ArticleId IdType="pmc">PMC4052529</ArticleId><ArticleId IdType="pubmed">24936435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox KC, Zhou L, Jordon JK, Huang Y, Yu Y, Redler RL, Chen X, Caplow M, Dokholyan NV. Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis. J Biol Chem. 2009;284(20):13940&#x2013;13947. doi: 10.1074/jbc.M809687200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809687200</ArticleId><ArticleId IdType="pmc">PMC2679493</ArticleId><ArticleId IdType="pubmed">19299510</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino SM, Gladyshev VN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol. 2010;404(5):902&#x2013;916. doi: 10.1016/j.jmb.2010.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2010.09.027</ArticleId><ArticleId IdType="pmc">PMC3061813</ArticleId><ArticleId IdType="pubmed">20950627</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano N, Ota M, Nishikawa K. Strong hydrophobic nature of cysteine residues in proteins. FEBS Lett. 1999;458(1):69&#x2013;71. doi: 10.1016/s0014-5793(99)01122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(99)01122-9</ArticleId><ArticleId IdType="pubmed">10518936</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson CM. Protein folding and misfolding. Nature. 2003;426(6968):884&#x2013;890. doi: 10.1038/nature02261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02261</ArticleId><ArticleId IdType="pubmed">14685248</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332&#x2013;1340. doi: 10.1038/s41593-018-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0235-9</ArticleId><ArticleId IdType="pmc">PMC6432913</ArticleId><ArticleId IdType="pubmed">30250260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara K, Fujiwara N, Yamaguchi Y, Torigoe H, Wakatsuki S, Taniguchi N, Suzuki K. Structural switching of Cu,Zn-superoxide dismutases at loop VI: insights from the crystal structure of 2-mercaptoethanol-modified enzyme. Biosci Rep. 2012;32(6):539&#x2013;548. doi: 10.1042/bsr20120029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bsr20120029</ArticleId><ArticleId IdType="pmc">PMC3497728</ArticleId><ArticleId IdType="pubmed">22804629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn TR, Radford SE. The Yin and Yang of protein folding. FEBS J. 2005;272(23):5962&#x2013;5970. doi: 10.1111/j.1742-4658.2005.05021.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.05021.x</ArticleId><ArticleId IdType="pubmed">16302961</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, Lehmann M, Beaudin M, Nordstr&#xf6;m U, Saikali S, Julien JP, Gilthorpe JD, Marklund SL, Cashman NR, Andersen PM, Forsberg K, Dupr&#xe9; N, Gould P, Br&#xe4;nnstr&#xf6;m T, Gros-Louis F. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci Rep. 2018;8(1):14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V, Walker AK, Yerbury J, Soo KY, Farg MA, Hoang V, Zeineddine R, Spencer D, Atkin JD. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol Life Sci. 2013;70(21):4181&#x2013;4195. doi: 10.1007/s00018-013-1385-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1385-2</ArticleId><ArticleId IdType="pubmed">23765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks CJ, Andersen JL. Mechanisms of SOD1 regulation by post-translational modifications. Redox Biol. 2019;26:101270. doi: 10.1016/j.redox.2019.101270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101270</ArticleId><ArticleId IdType="pmc">PMC6658992</ArticleId><ArticleId IdType="pubmed">31344643</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiliana A, Dewi NM, Wijaya A. New insight in the molecular mechanisms of neurodegenerative disease. Indones Biomed J. 2018;10(1):16&#x2013;34. doi: 10.18585/inabj.v10i1.448.</Citation><ArticleIdList><ArticleId IdType="doi">10.18585/inabj.v10i1.448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner AB, Demarez A. Protein aggregation as a paradigm of aging. Biochim Biophys Acta. 2009;1790(10):980&#x2013;996. doi: 10.1016/j.bbagen.2009.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2009.06.005</ArticleId><ArticleId IdType="pubmed">19527771</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebman SW, Chernoff YO. Prions in yeast. Genetics. 2012;191(4):1041&#x2013;1072. doi: 10.1534/genetics.111.137760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.111.137760</ArticleId><ArticleId IdType="pmc">PMC3415993</ArticleId><ArticleId IdType="pubmed">22879407</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Simons M. Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 2013;352(1):33&#x2013;47. doi: 10.1007/s00441-012-1428-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-012-1428-2</ArticleId><ArticleId IdType="pmc">PMC3602607</ArticleId><ArticleId IdType="pubmed">22610588</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroo E, Koopman M, Nollen EA, Mata-Cabana A. Cellular regulation of amyloid formation in aging and disease. Front Neurosci. 2017;11:64. doi: 10.3389/fnins.2017.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00064</ArticleId><ArticleId IdType="pmc">PMC5306383</ArticleId><ArticleId IdType="pubmed">28261044</ArticleId></ArticleIdList></Reference><Reference><Citation>Deller MC, Kong L, Rupp B. Protein stability: a crystallographer&#x2019;s perspective. Acta Crystallogr F Struct Biol Commun. 2016;72(Pt 2):72&#x2013;95. doi: 10.1107/s2053230x15024619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/s2053230x15024619</ArticleId><ArticleId IdType="pmc">PMC4741188</ArticleId><ArticleId IdType="pubmed">26841758</ArticleId></ArticleIdList></Reference><Reference><Citation>Farage MA, Miller KW, Elsner P, Maibach HI. Characteristics of the aging skin. Adv Wound Care (New Rochelle) 2013;2(1):5&#x2013;10. doi: 10.1089/wound.2011.0356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/wound.2011.0356</ArticleId><ArticleId IdType="pmc">PMC3840548</ArticleId><ArticleId IdType="pubmed">24527317</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M, Valentine JS. Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal. 2009;11(7):1603&#x2013;1614. doi: 10.1089/ars.2009.2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2536</ArticleId><ArticleId IdType="pmc">PMC2842589</ArticleId><ArticleId IdType="pubmed">19271992</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon GS, Shim YM, Lee DY, Kim JS, Kang M, Ahn SH, Shin JY, Geum D, Hong YH, Sung JJ. Pathological modification of TDP-43 in amyotrophic lateral sclerosis with SOD1 mutations. Mol Neurobiol. 2019;56(3):2007&#x2013;2021. doi: 10.1007/s12035-018-1218-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1218-2</ArticleId><ArticleId IdType="pmc">PMC6394608</ArticleId><ArticleId IdType="pubmed">29982983</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Hare DJ, Double KL. A Proposed mechanism for neurodegeneration in movement disorders characterized by metal dyshomeostasis and oxidative stress. Cell Chem Biol. 2018;25(7):807&#x2013;816. doi: 10.1016/j.chembiol.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2018.05.004</ArticleId><ArticleId IdType="pubmed">29861271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer D, Talbot K, Turner MR. Advances in motor neurone disease. J R Soc Med. 2014;107(1):14&#x2013;21. doi: 10.1177/0141076813511451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0141076813511451</ArticleId><ArticleId IdType="pmc">PMC3883149</ArticleId><ArticleId IdType="pubmed">24399773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH, Jr, Naniche N, Kia A, Trotti D, Pasinelli P. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet. 2010;19(15):2974&#x2013;2986. doi: 10.1093/hmg/ddq202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq202</ArticleId><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwiegers P, Lee G, Shaw CA. Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents. J Negat Results Biomed. 2014;13:14. doi: 10.1186/1477-5751-13-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-5751-13-14</ArticleId><ArticleId IdType="pmc">PMC4134475</ArticleId><ArticleId IdType="pubmed">25103619</ArticleId></ArticleIdList></Reference><Reference><Citation>Davie CA. A review of Parkinson&#x2019;s disease. Br Med Bull. 2008;86:109&#x2013;127. doi: 10.1093/bmb/ldn013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldn013</ArticleId><ArticleId IdType="pubmed">18398010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle MD, Comellas G, Nieuwkoop AJ, Covell DJ, Berthold DA, Kloepper KD, Courtney JM, Kim JK, Barclay AM, Kendall A, Wan W, Stubbs G, Schwieters CD, Lee VMY, George JM, Rienstra CM. Solid-state NMR structure of a pathogenic fibril of full-length human &#x3b1;-synuclein. Nat Struct Mol Biol. 2016;23(5):409&#x2013;415. doi: 10.1038/nsmb.3194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3194</ArticleId><ArticleId IdType="pmc">PMC5034296</ArticleId><ArticleId IdType="pubmed">27018801</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields CR, Bengoa-Vergniory N, Wade-Martins R. Targeting Alpha-synuclein as a therapy for Parkinson&#x2019;s disease. Front Mol Neurosci. 2019;12:299. doi: 10.3389/fnmol.2019.00299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00299</ArticleId><ArticleId IdType="pmc">PMC6906193</ArticleId><ArticleId IdType="pubmed">31866823</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;ck D, Wenning GK, Stefanova N, Fellner L. Glia and alpha-synuclein in neurodegeneration: a complex interaction. Neurobiol Dis. 2016;85:262&#x2013;274. doi: 10.1016/j.nbd.2015.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.03.003</ArticleId><ArticleId IdType="pmc">PMC4730552</ArticleId><ArticleId IdType="pubmed">25766679</ArticleId></ArticleIdList></Reference><Reference><Citation>Trist BG, Davies KM, Cottam V, Genoud S, Ortega R, Roudeau S, Carmona A, de Silva K, Wasinger V, Lewis SJG, Sachdev P, Smith B, Troakes C, Vance C, Shaw C, al-Sarraj S, Ball HJ, Halliday GM, Hare DJ, Double KL. Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson&#x2019;s disease brain. Acta Neuropathol. 2017;134(1):113&#x2013;127. doi: 10.1007/s00401-017-1726-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1726-6</ArticleId><ArticleId IdType="pubmed">28527045</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruces-Sande A, M&#xe9;ndez-&#xc1;lvarez E, Soto-Otero R. Copper increases the ability of 6-hydroxydopamine to generate oxidative stress and the ability of ascorbate and glutathione to potentiate this effect: potential implications in Parkinson&#x2019;s disease. J Neurochem. 2017;141(5):738&#x2013;749. doi: 10.1111/jnc.14019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14019</ArticleId><ArticleId IdType="pubmed">28294337</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG. A century of Alzheimer&#x2019;s disease. Science. 2006;314(5800):777&#x2013;781. doi: 10.1126/science.1132814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132814</ArticleId><ArticleId IdType="pubmed">17082447</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239&#x2013;259. doi: 10.1007/bf00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurfuerst S. Stop before it starts. Rehab Manag. 2003;16(8):42&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">14558425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuello AC. Intracellular and extracellular Abeta, a tale of two neuropathologies. Brain Pathol. 2005;15(1):66&#x2013;71. doi: 10.1111/j.1750-3639.2005.tb00101.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2005.tb00101.x</ArticleId><ArticleId IdType="pmc">PMC8095923</ArticleId><ArticleId IdType="pubmed">15779238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Fu Z, Meng L, He M, Zhang Z. The early events that initiate &#x3b2;-amyloid aggregation in Alzheimer&#x2019;s disease. Front Aging Neurosci. 2018;10:359. doi: 10.3389/fnagi.2018.00359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00359</ArticleId><ArticleId IdType="pmc">PMC6277872</ArticleId><ArticleId IdType="pubmed">30542277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JY, Cho H, Park HY, Rhim H, Kang S. ALS-linked mutant SOD1 proteins promote A&#x3b2; aggregates in ALS through direct interaction with A&#x3b2;. Biochem Biophys Res Commun. 2017;493(1):697&#x2013;707. doi: 10.1016/j.bbrc.2017.08.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.08.127</ArticleId><ArticleId IdType="pubmed">28864422</ArticleId></ArticleIdList></Reference><Reference><Citation>Moszczynski AJ, Hintermayer MA, Strong MJ. Phosphorylation of threonine 175 tau in the induction of tau pathology in amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD). A review. Front Neurosci. 2018;12:259. doi: 10.3389/fnins.2018.00259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00259</ArticleId><ArticleId IdType="pmc">PMC5919950</ArticleId><ArticleId IdType="pubmed">29731706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>